Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409237 | SCV000485989 | likely pathogenic | Pyknodysostosis | 2016-03-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000409237 | SCV004215266 | likely pathogenic | Pyknodysostosis | 2022-06-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003766126 | SCV004683548 | pathogenic | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs758450569, gnomAD 0.0009%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370625). This variant has not been reported in the literature in individuals affected with CTSK-related conditions. This sequence change creates a premature translational stop signal (p.Ile227Lysfs*10) in the CTSK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTSK are known to be pathogenic (PMID: 12125807, 21569238). |